leadf
logo-loader
viewNeurotez

Neurotez developing a unique therapy to treat Alzheimer’s disease

Neurotez Inc CEO Nikolaos Tezapsidis sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The New Jersey-based company is focused on development treatments and therapies for Alzheimer’s, dementia and other aging-related illnesses.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Cabral Gold adds 2nd drill rig as company identifies new high-grade veins

Cabral Gold (CVE: CBR-OTC: CBGZF) CEO Alan Carter joined Steve Darling from Proactive Vancouver with news the company has identified at least six new NE trending high-grade veins in the Machichie SW area located immediately north of the MG deposit. Carter telling Proactive what had led them...

1 day, 11 hours ago

2 min read